![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 20, 15363-15369, May 19, 2000
From the Genistein, a natural isoflavone found in
soybeans, exerts a number of biological actions suggesting that it may
have a role in cancer prevention. We have previously shown that it
potently inhibits OCM-1 melanoma cell proliferation by inducing a
G2 cell cycle arrest. Here we show that genistein
exerts this effect by impairing the Cdc25C-dependent Tyr-15
dephosphorylation of Cdk1, as the overexpression of this phosphatase
allows the cells to escape G2 arrest and enter an abnormal
chromatin condensation stage. Caffeine totally overrides the
genistein-induced G2 arrest, whereas the block caused by
etoposide is not bypassed and that caused by adriamycin is only
partially abolished. We also report that genistein activates the
checkpoint kinase Chk2 as efficiently as the two genotoxic agents and
that caffeine may counteract the activation of Chk2 by genistein but
not by etoposide. In contrast, caffeine abolishes the accumulation of
p53 caused by all the compounds. Wortmannin does not suppress the Chk2
activation in any situation, suggesting that the ataxia
telangiectasia-mutated kinase is not involved in this regulation.
Finally, unlike etoposide and adriamycin, genistein induces only a weak
response in terms of DNA damage in OCM-1 cells. Taken together, these
results suggest that the G2 checkpoints activated by
genistein and the two genotoxic agents involve different pathways.
Distinct Chk2 Activation Pathways Are Triggered by Genistein and
DNA-damaging Agents in Human Melanoma Cells*
§,
,
,
¶,
,
, and
Laboratoire de Biologie
Cellulaire et Moléculaire du Contrôle de la
Prolifération Cellulaire, UMR 5088 CNRS, Université Paul
Sabatier, 118 Route de Narbonne, 31062 Toulouse Cedex and the
Institut de Recherche Pierre Fabre, Faculté de
Médecine Rangueil, 133 Route de Narbonne,
31062 Toulouse, France
*
This work was supported by INSERM, Université Paul
Sabatier, Association pour la Recherche sur le Cancer, and Ligue
Nationale Contre le Cancer.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
T. Choudhuri, S. C. Verma, K. Lan, M. Murakami, and E. S. Robertson The ATM/ATR Signaling Effector Chk2 Is Targeted by Epstein-Barr Virus Nuclear Antigen 3C To Release the G2/M Cell Cycle Block J. Virol., June 15, 2007; 81(12): 6718 - 6730. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Visanji, S. J. Duthie, L. Pirie, D. G. Thompson, and P. J. Padfield Dietary Isothiocyanates Inhibit Caco-2 Cell Proliferation and Induce G2/M Phase Cell Cycle Arrest, DNA Damage, and G2/M Checkpoint Activation J. Nutr., November 1, 2004; 134(11): 3121 - 3126. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Shin, S.-H. Kim, D. Kim, Y.-H. Kim, H.-W. Lee, Y.-S. Chang, M.-B. Gu, S. H. Ryu, and P.-G. Suh 2,2',4,6,6'-Pentachlorobiphenyl Induces Mitotic Arrest and p53 Activation Toxicol. Sci., April 1, 2004; 78(2): 215 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Frey and K. W. Singletary Genistein Activates p38 Mitogen-Activated Protein Kinase, Inactivates ERK1/ERK2 and Decreases Cdc25C Expression in Immortalized Human Mammary Epithelial Cells J. Nutr., January 1, 2003; 133(1): 226 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ye, A. Bodero, B.-B. Zhou, K. K. Khanna, M. F. Lavin, and S. P. Lees-Miller The Plant Isoflavenoid Genistein Activates p53 and Chk2 in an ATM-dependent Manner J. Biol. Chem., February 9, 2001; 276(7): 4828 - 4833. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Doostzadeh-Cizeron, N. H. A. Terry, and D. W. Goodrich The Nuclear Death Domain Protein p84N5 Activates a G2/M Cell Cycle Checkpoint Prior to the Onset of Apoptosis J. Biol. Chem., January 5, 2001; 276(2): 1127 - 1132. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |